RhizoBriva is a patented, robust, scalable, highly stable and easily transferable bioreactor-confined bioprocessing technology which demonstrated its potential for both complex recombinant proteins and secondary metabolites production.
Production of molecules of interest:
- from a single clone cultured for an indefinite period of time,
- using a fully controlled process enabling a strong reproducibility with a constant productivity over time
- from dedicated "Master Root Banks" / "Working Root Banks"
- using a cost-effective system (low capex & COGS, low initial investment, culture at room temperature, in a very simple medium, secretion in the culture medium, enabling a straightforward purification...)
